Clinical pharmacology of sodium butyrate in patients with acute leukemia
- 1 September 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (9), 1283-1287
- https://doi.org/10.1016/0277-5379(87)90109-x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Effects of sodium n-butyrate on alpha-fetoprotein and albumin secretion in the human hepatoma cell line PLC/PRF/5British Journal of Cancer, 1985
- Differentiation modifiersCancer, 1984
- Increase in histone acetylation and transitions in histone variants during friend cell differentiationExperimental Cell Research, 1984
- Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0- tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrateBlood, 1984
- Effects of sodium butyrate and dimethylsulfoxide on human pancreatic tumor cell linesEuropean Journal of Cancer and Clinical Oncology, 1984
- Conservation of the acetylation pattern of histones and the transcriptional activity in Ehrlich ascites tumor cells by sodium butyrateArchives of Biochemistry and Biophysics, 1983
- 5-Methylcytosine, Gene Regulation, and CancerAdvances in Cancer Research, 1983
- Induction of erythroid differentiation in the human leukaemia cell line K562Nature, 1979
- Effects of sodium butyrate on mouse neuroblastoma cells in cultureBiochemical Pharmacology, 1976
- Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cellsCell, 1975